Tag - ELGX

Developments

Endologix gets CE Mark for ALTO abdominal stent graft system

Endologix (NASDAQ:ELGX) received a CE Mark for its ALTO abdominal stent graft system. ALTO is an endovascular aneurysm repair device designed to increase patient applicability and technical success rate, and improve...

August 5, 2020

Markets

BTIG cuts Endologix to neutral; removes price target

BTIG downgraded Endologix (NASDAQ:ELGX) to “neutral” without a price target, citing “greater uncertainty” that the potential COVID-19 impact on revenue could put the company’s financial covenants in peril. The stock...

May 12, 2020

Markets

BTIG halves Endologix PT to $6 from $12

BTIG halved its price target for Endologix (NASDAQ:ELGX) to $6 from $12, but maintained its “buy” rating, saying the new target better reflects the current stock price, which closed at 89 cents on Feb. 19. Endologix...

February 20, 2020

Tag - ELGX

Endologix gets CE Mark for ALTO abdominal stent graft system

BTIG cuts Endologix to neutral; removes price target

BTIG halves Endologix PT to $6 from $12

General

More